Glaucoma Screening to Enhance At-Risk Californians' Health
Novel Telehealth Technologies to Detect and Manage Glaucoma and Vision-threatening Eye Diseases in High-risk Populations
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 50 Years and older
- Sex
- All sexes
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests whether eye screening finds more cases of glaucoma than education alone or screening later. Glaucoma is an eye disease that gets worse over time and may have no symptoms at first. The study is for older Black or Hispanic people, or people with diabetes, who recently visited a qualifying health center.
The vast majority of glaucoma cases in the United States go undetected and untreated until the late stages of the disease. Open-angle glaucoma is a progressive condition that is asymptomatic in its early to moderate stages and may be amenable to screening through telemedicine-based approaches. This study is a randomized trial to evaluate whether glaucoma screening with established tests (e.g., optical coherence tomography, fundus photography, and tonometry) is more effective for detecting undiagnosed glaucoma cases compared to education alone or delayed intervention.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Meet at least one of these: Black and age 50 or older; Hispanic and age 65 or older; or have diabetes and be age 50 or older.
- Have been seen at the Federally Qualified Health Center (FQHC), a community health center, within the past month.
Who can't join
- Do not have a valid phone number or mailing address.
- Have had an appointment with an optometrist (an eye care provider) within the past year.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Black people aged 50 years or older * Hispanic people aged 65 years or older * People with diabetes aged 50 years or older * Must have been seen at the Federally Qualified Health Center (FQHC) within the past month Exclusion Criteria: * Patients without a valid phone number or mailing address * Patients who have had an optometry appointment within the past year
Study sites (3)
CA
- Bay Area Community Health · Fremont, CA 94538Piper Bahr, OD, FAAO · Study contact · 510-770-8133 · pbahr1@bach.healthMore trials in Fremont
- Baywell Health · Oakland, CA 94607Angela Shahbazian, OD, FAAO · Study contact · 510-835-9610 · a.shahbazian@berkeley.eduMore trials in Oakland
- University of California, San Francisco · San Francisco, CA 94158More trials in San Francisco